Alnylam Pharmaceuticals
ALNY
$147.89
Share price
-1.33%
Change (1 day)
-28.28%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Alnylam Pharmaceuticals (ALNY) - Net assets
Net assets on the balance sheet as of March 2024 : -$0.22 B
According to Alnylam Pharmaceuticals
's latest financial reports the company has -$0.22 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.23 B | 39.45% |
| 2022-12-31 | $-0.16 B | -126.9% |
| 2021-12-31 | $0.58 B | -42.12% |
| 2020-12-31 | $1.01 B | -29.36% |
| 2019-12-31 | $1.43 B | 10.5% |
| 2018-12-31 | $1.30 B | -26.29% |
| 2017-12-31 | $1.76 B | 91.96% |
| 2016-12-31 | $0.92 B | -27.24% |
| 2015-12-31 | $1.26 B | 35.08% |
| 2014-12-31 | $0.93 B | 246.32% |
| 2013-12-31 | $0.27 B | 101.67% |
| 2012-12-31 | $0.13 B | 13.61% |
| 2011-12-31 | $0.11 B | -25.43% |
| 2010-12-31 | $0.15 B | -11.09% |
| 2009-12-31 | $0.17 B | -11.95% |
| 2008-12-31 | $0.20 B | 1.48% |
| 2007-12-31 | $0.19 B | -1% |
| 2006-12-31 | $0.20 B | 225.63% |
| 2005-12-31 | $61.77 M | 33.89% |
| 2004-12-31 | $46.14 M | -272.77% |
| 2003-12-31 | $-26.71 M | 474.84% |
| 2002-12-31 | $-4.65 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $39.75 B | -18,230.91% | 🇨🇭 Switzerland |
 Sanofi SNY | $82.20 B | -37,589.24% | 🇫🇷 France |
 Regeneron Pharmaceuticals REGN | $26.99 B | -12,409.41% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $0.96 B | -538.36% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $21.18 M | -109.66% | 🇺🇸 USA |
 OPKO Health
OPK | $1.38 B | -733.56% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.12 B | -3,805.90% | 🇮🇱 Israel |
 Arrowhead Pharmaceuticals
ARWR | $0.17 B | -179.22% | 🇺🇸 USA |